Skip to main content

ISMPP U - Let’s Get #Social with Published Research

Thank you

“Open Twitter... Close Twitter... Open Twitter... Where do I begin?”
Social media has been widely used for sharing health-related information, especially during the COVID-19 pandemic. It has been used for health interventions, health campaigns, medical education, disease outbreak surveillance, advancing scientific research and practice, and social mobilization, among other uses1.Although it is seemingly easy to open a social media account, the guidance around implementation and use of social media, specifically with regard to scientific publications, remains scarce and inconsistent.

This ISMPP U provides a unique opportunity to hear from, and question, renowned experts from the regulatory, publishing, and pharmaceutical industries. Perspectives on the role of social media within scientific publications, potential considerations, differences between sharing disease state versus results publications, and guidance and best practices will be shared.

Learning Objectives
At the end of this sessions, participants should be able to:

  • Differentiate between the potential uses of social media within scientific publications
  • Identify and describe organizations’ practices and guidance related to social media
  • Acquire knowledge about the practical considerations for implementation of social media strategy
Collaborate with industry partners to disseminate research and scientific publications

Chen J, Wang Y. Social media use for health purposes: systematic review. J Med Internet Res 2021;23(5):e17917.
Approved for 1.5 ISMPP CMPP certification credit


  • Tomas Rees, Director of Innovation, Oxford PharmaGenesis

    • Medical communications professional with over 20 years industry experience
    • Keen interest in measuring and increasing the impact of publications.
    • Member of the ISMPP Social Media working group for the past 4 years
    • Co-author on several ISMPP posters and articles on the use of social media in publication planning

  • Kelly Soldavin, Senior Editor, Original Research Journals Medicine & Health/ Taylor & Francis Group

    • Senior Editor with Taylor & Francis Group, managing a portfolio of clinical medicine research journals
    • Passionate about ethical, accessible, and innovative publishing, with a focus on omni-channel research communication
    • Speaker and moderator for ISMPP annual meetings, ISMPP U webinars, and other industry conferences
    • Member of ISMPP Social Media & Web-based Metrics working group and ISMPP Annual Meeting program committee

  • Hetal Patel, MD, Boehringer Ingelheim International

    • Five years of experience in Medical Publications and 20 years in Pharma
    • Early adopter of digital extenders, PLS/PLSP, and Social Media use in Publications
    • Presented at ISMPP 2021 on Digital Enhancements in Publications

  • Ajit Kulkarni, Social & Medical Digital Strategy & Comms, Novartis

    • Experienced in academia and Pharma Medical Affairs. [Ajit has authored, co-authored 15 scientific papers, and has served on the editorial board of Scientific Reports (npg).]
    • Provides strategic and operational guidance for US Novartis Pharma medical Twitter and LinkedIn channels
    • Highly interested in the impact of novel digital platforms on pharma medical communication

  • Dikran Toroser, PhD CMPP, Senior Director, Publications, Merck

    • Dikran holds a PhD in Biochemistry/Molecular Biology from Newcastle upon Tyne (UK). He did his post-doc at the Cambridge lab (UK) on genetics and then moved to the US to work as a biochemist/researcher for the USDA and UNC. 
    • He has been in Pharma since 2004. Most recently at Amgen and Takeda as a Publications Group Lead. 
    • Dikran has an extensive background in publication planning as well as medical writing. He has held leadership roles in many therapeutic areas, including: Immunology, hematology, rare diseases, cardiovascular, neuroscience and vaccines.
    • Dikran is active in publications-related professional organizations (AMWA, ISMPP and ACSE) and most recently has been involved in compiling guidelines for the publications profession (eg, AMWA/EMWA/ISMPP Joint Position Statement and “GPP4”, the Good Publication Guidelines. He is one of the founder faculty for the UC San Diego medical writing certificate and a consulting director. 

  • Sue Egan, Sue Eagan Associates Limited

    • Former ethics and compliance leader in pharmaceutical companies from single country to International Vice President
    • Consultant for global, regional, and country clients in matters relating to business ethics and compliance
    • Renowned trainer and congress speaker

June 22, 2022
Wed 11:00 AM EDT

Duration 1H 30M

This live web event has ended.

ISMPP U Support